Abstract
Summary
Branched chain amino acids (BCAA)-leucine, isoleucine and valine are essential amino acids which are metabolized directly in muscles and offer energy fuel to performance of the work. There is lot of evidences supporting the positive effect of BCAA supplementation on muscle growth. The main importance is attached particularly to leucine.
LPI (LP Information)' newest research report, the “Branched Chain Amino Acids (BCAAs) Industry Forecast” looks at past sales and reviews total world Branched Chain Amino Acids (BCAAs) sales in 2022, providing a comprehensive analysis by region and market sector of projected Branched Chain Amino Acids (BCAAs) sales for 2023 through 2029. With Branched Chain Amino Acids (BCAAs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Branched Chain Amino Acids (BCAAs) industry.
This Insight Report provides a comprehensive analysis of the global Branched Chain Amino Acids (BCAAs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Branched Chain Amino Acids (BCAAs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Branched Chain Amino Acids (BCAAs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Branched Chain Amino Acids (BCAAs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Branched Chain Amino Acids (BCAAs).
The global Branched Chain Amino Acids (BCAAs) market size is projected to grow from US$ 241.4 million in 2022 to US$ 307.7 million in 2029; it is expected to grow at a CAGR of 307.7 from 2023 to 2029.
Commercially, Classification of BCAA is usually based on the ratio of Leucine, Isoleucine and Valine. the most common type of BCAA is composed of Leucine, Isoleucine and Valine with ratio at 2:1:1. The 2:1:1 BCAA takes 87% share of global market. Others include 4:1:1, 8:1:1 etc. Application of BCAA can be broadly categized as Sports Nutrition, Pharmaceutical and Others. Sports Nutrition is the major application of BCAA, with market share of 93% in terms of consumption volume.
At present, the BCAA production market concentrates in USA, Europe, China, Japan. China is the largest production country of BCAA in the world in the past few years and it will keep the same position in the next few years. The China market took up about 34% the global market, followed by Japan (25%). In contrast to the production scenario, the consumption of BCAA is concentrated in USA and Europe, which combinedly takes market share of 57%.
Ajinomoto, Kyowa Hakko, Evonik, Fufeng Group and Luzhou are the key suppliers in the global L-valine market. Top five take up about 73% of the global production market. And the production of Ajinomoto occupied about 37%, which supplies BCAA supplement raw material to dozens of companies in USA and Europe.
This report presents a comprehensive overview, market shares, and growth opportunities of Branched Chain Amino Acids (BCAAs) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
L-Leucine
L-Isoleucine
L-Valine
Segmentation by application
Food & Beverages
Animal Feed
Pharmaceuticals
Cosmetics
Personal Care
Sports Nutrition & Fitness
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amino GmbH (Germany)
Nippon Rika Co., Ltd. (Japan)
Kyowa Hakko Bio Co., Ltd. (Japan)
Fufeng Group Company Limited (China)
Ajinomoto Co., Inc. (Japan)s
CJ CheilJedang Corporation (South Korea)
Evonik Industries AG (Germany)
Meihua Holdings Group Co., Ltd. (China)
Shantou Jiahe Biological Technology Co., Ltd. (China)
Daesang Corporation (South Korea)
Taj Agro Products (India)
Nutra Green (U.S.)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Branched Chain Amino Acids (BCAAs) market?
What factors are driving Branched Chain Amino Acids (BCAAs) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Branched Chain Amino Acids (BCAAs) market opportunities vary by end market size?
How does Branched Chain Amino Acids (BCAAs) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Branched Chain Amino Acids (BCAAs) Industry Forecast” looks at past sales and reviews total world Branched Chain Amino Acids (BCAAs) sales in 2022, providing a comprehensive analysis by region and market sector of projected Branched Chain Amino Acids (BCAAs) sales for 2023 through 2029. With Branched Chain Amino Acids (BCAAs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Branched Chain Amino Acids (BCAAs) industry.
This Insight Report provides a comprehensive analysis of the global Branched Chain Amino Acids (BCAAs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Branched Chain Amino Acids (BCAAs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Branched Chain Amino Acids (BCAAs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Branched Chain Amino Acids (BCAAs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Branched Chain Amino Acids (BCAAs).
The global Branched Chain Amino Acids (BCAAs) market size is projected to grow from US$ 241.4 million in 2022 to US$ 307.7 million in 2029; it is expected to grow at a CAGR of 307.7 from 2023 to 2029.
Commercially, Classification of BCAA is usually based on the ratio of Leucine, Isoleucine and Valine. the most common type of BCAA is composed of Leucine, Isoleucine and Valine with ratio at 2:1:1. The 2:1:1 BCAA takes 87% share of global market. Others include 4:1:1, 8:1:1 etc. Application of BCAA can be broadly categized as Sports Nutrition, Pharmaceutical and Others. Sports Nutrition is the major application of BCAA, with market share of 93% in terms of consumption volume.
At present, the BCAA production market concentrates in USA, Europe, China, Japan. China is the largest production country of BCAA in the world in the past few years and it will keep the same position in the next few years. The China market took up about 34% the global market, followed by Japan (25%). In contrast to the production scenario, the consumption of BCAA is concentrated in USA and Europe, which combinedly takes market share of 57%.
Ajinomoto, Kyowa Hakko, Evonik, Fufeng Group and Luzhou are the key suppliers in the global L-valine market. Top five take up about 73% of the global production market. And the production of Ajinomoto occupied about 37%, which supplies BCAA supplement raw material to dozens of companies in USA and Europe.
This report presents a comprehensive overview, market shares, and growth opportunities of Branched Chain Amino Acids (BCAAs) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
L-Leucine
L-Isoleucine
L-Valine
Segmentation by application
Food & Beverages
Animal Feed
Pharmaceuticals
Cosmetics
Personal Care
Sports Nutrition & Fitness
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amino GmbH (Germany)
Nippon Rika Co., Ltd. (Japan)
Kyowa Hakko Bio Co., Ltd. (Japan)
Fufeng Group Company Limited (China)
Ajinomoto Co., Inc. (Japan)s
CJ CheilJedang Corporation (South Korea)
Evonik Industries AG (Germany)
Meihua Holdings Group Co., Ltd. (China)
Shantou Jiahe Biological Technology Co., Ltd. (China)
Daesang Corporation (South Korea)
Taj Agro Products (India)
Nutra Green (U.S.)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Branched Chain Amino Acids (BCAAs) market?
What factors are driving Branched Chain Amino Acids (BCAAs) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Branched Chain Amino Acids (BCAAs) market opportunities vary by end market size?
How does Branched Chain Amino Acids (BCAAs) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Branched Chain Amino Acids (BCAAs) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Branched Chain Amino Acids (BCAAs) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Branched Chain Amino Acids (BCAAs) by Country/Region, 2018, 2022 & 2029
2.2 Branched Chain Amino Acids (BCAAs) Segment by Type
2.2.1 L-Leucine
2.2.2 L-Isoleucine
2.2.3 L-Valine
2.3 Branched Chain Amino Acids (BCAAs) Sales by Type
2.3.1 Global Branched Chain Amino Acids (BCAAs) Sales Market Share by Type (2018-2023)
2.3.2 Global Branched Chain Amino Acids (BCAAs) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Branched Chain Amino Acids (BCAAs) Sale Price by Type (2018-2023)
2.4 Branched Chain Amino Acids (BCAAs) Segment by Application
2.4.1 Food & Beverages
2.4.2 Animal Feed
2.4.3 Pharmaceuticals
2.4.4 Cosmetics
2.4.5 Personal Care
2.4.6 Sports Nutrition & Fitness
2.4.7 Others
2.5 Branched Chain Amino Acids (BCAAs) Sales by Application
2.5.1 Global Branched Chain Amino Acids (BCAAs) Sale Market Share by Application (2018-2023)
2.5.2 Global Branched Chain Amino Acids (BCAAs) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Branched Chain Amino Acids (BCAAs) Sale Price by Application (2018-2023)
3 Global Branched Chain Amino Acids (BCAAs) by Company
3.1 Global Branched Chain Amino Acids (BCAAs) Breakdown Data by Company
3.1.1 Global Branched Chain Amino Acids (BCAAs) Annual Sales by Company (2018-2023)
3.1.2 Global Branched Chain Amino Acids (BCAAs) Sales Market Share by Company (2018-2023)
3.2 Global Branched Chain Amino Acids (BCAAs) Annual Revenue by Company (2018-2023)
3.2.1 Global Branched Chain Amino Acids (BCAAs) Revenue by Company (2018-2023)
3.2.2 Global Branched Chain Amino Acids (BCAAs) Revenue Market Share by Company (2018-2023)
3.3 Global Branched Chain Amino Acids (BCAAs) Sale Price by Company
3.4 Key Manufacturers Branched Chain Amino Acids (BCAAs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Branched Chain Amino Acids (BCAAs) Product Location Distribution
3.4.2 Players Branched Chain Amino Acids (BCAAs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Branched Chain Amino Acids (BCAAs) by Geographic Region
4.1 World Historic Branched Chain Amino Acids (BCAAs) Market Size by Geographic Region (2018-2023)
4.1.1 Global Branched Chain Amino Acids (BCAAs) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Branched Chain Amino Acids (BCAAs) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Branched Chain Amino Acids (BCAAs) Market Size by Country/Region (2018-2023)
4.2.1 Global Branched Chain Amino Acids (BCAAs) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Branched Chain Amino Acids (BCAAs) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Branched Chain Amino Acids (BCAAs) Sales Growth
4.4 APAC Branched Chain Amino Acids (BCAAs) Sales Growth
4.5 Europe Branched Chain Amino Acids (BCAAs) Sales Growth
4.6 Middle East & Africa Branched Chain Amino Acids (BCAAs) Sales Growth
5 Americas
5.1 Americas Branched Chain Amino Acids (BCAAs) Sales by Country
5.1.1 Americas Branched Chain Amino Acids (BCAAs) Sales by Country (2018-2023)
5.1.2 Americas Branched Chain Amino Acids (BCAAs) Revenue by Country (2018-2023)
5.2 Americas Branched Chain Amino Acids (BCAAs) Sales by Type
5.3 Americas Branched Chain Amino Acids (BCAAs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Branched Chain Amino Acids (BCAAs) Sales by Region
6.1.1 APAC Branched Chain Amino Acids (BCAAs) Sales by Region (2018-2023)
6.1.2 APAC Branched Chain Amino Acids (BCAAs) Revenue by Region (2018-2023)
6.2 APAC Branched Chain Amino Acids (BCAAs) Sales by Type
6.3 APAC Branched Chain Amino Acids (BCAAs) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Branched Chain Amino Acids (BCAAs) by Country
7.1.1 Europe Branched Chain Amino Acids (BCAAs) Sales by Country (2018-2023)
7.1.2 Europe Branched Chain Amino Acids (BCAAs) Revenue by Country (2018-2023)
7.2 Europe Branched Chain Amino Acids (BCAAs) Sales by Type
7.3 Europe Branched Chain Amino Acids (BCAAs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Branched Chain Amino Acids (BCAAs) by Country
8.1.1 Middle East & Africa Branched Chain Amino Acids (BCAAs) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Branched Chain Amino Acids (BCAAs) Revenue by Country (2018-2023)
8.2 Middle East & Africa Branched Chain Amino Acids (BCAAs) Sales by Type
8.3 Middle East & Africa Branched Chain Amino Acids (BCAAs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Branched Chain Amino Acids (BCAAs)
10.3 Manufacturing Process Analysis of Branched Chain Amino Acids (BCAAs)
10.4 Industry Chain Structure of Branched Chain Amino Acids (BCAAs)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Branched Chain Amino Acids (BCAAs) Distributors
11.3 Branched Chain Amino Acids (BCAAs) Customer
12 World Forecast Review for Branched Chain Amino Acids (BCAAs) by Geographic Region
12.1 Global Branched Chain Amino Acids (BCAAs) Market Size Forecast by Region
12.1.1 Global Branched Chain Amino Acids (BCAAs) Forecast by Region (2024-2029)
12.1.2 Global Branched Chain Amino Acids (BCAAs) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Branched Chain Amino Acids (BCAAs) Forecast by Type
12.7 Global Branched Chain Amino Acids (BCAAs) Forecast by Application
13 Key Players Analysis
13.1 Amino GmbH (Germany)
13.1.1 Amino GmbH (Germany) Company Information
13.1.2 Amino GmbH (Germany) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.1.3 Amino GmbH (Germany) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amino GmbH (Germany) Main Business Overview
13.1.5 Amino GmbH (Germany) Latest Developments
13.2 Nippon Rika Co., Ltd. (Japan)
13.2.1 Nippon Rika Co., Ltd. (Japan) Company Information
13.2.2 Nippon Rika Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.2.3 Nippon Rika Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nippon Rika Co., Ltd. (Japan) Main Business Overview
13.2.5 Nippon Rika Co., Ltd. (Japan) Latest Developments
13.3 Kyowa Hakko Bio Co., Ltd. (Japan)
13.3.1 Kyowa Hakko Bio Co., Ltd. (Japan) Company Information
13.3.2 Kyowa Hakko Bio Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.3.3 Kyowa Hakko Bio Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Kyowa Hakko Bio Co., Ltd. (Japan) Main Business Overview
13.3.5 Kyowa Hakko Bio Co., Ltd. (Japan) Latest Developments
13.4 Fufeng Group Company Limited (China)
13.4.1 Fufeng Group Company Limited (China) Company Information
13.4.2 Fufeng Group Company Limited (China) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.4.3 Fufeng Group Company Limited (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fufeng Group Company Limited (China) Main Business Overview
13.4.5 Fufeng Group Company Limited (China) Latest Developments
13.5 Ajinomoto Co., Inc. (Japan)s
13.5.1 Ajinomoto Co., Inc. (Japan)s Company Information
13.5.2 Ajinomoto Co., Inc. (Japan)s Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.5.3 Ajinomoto Co., Inc. (Japan)s Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ajinomoto Co., Inc. (Japan)s Main Business Overview
13.5.5 Ajinomoto Co., Inc. (Japan)s Latest Developments
13.6 CJ CheilJedang Corporation (South Korea)
13.6.1 CJ CheilJedang Corporation (South Korea) Company Information
13.6.2 CJ CheilJedang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.6.3 CJ CheilJedang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CJ CheilJedang Corporation (South Korea) Main Business Overview
13.6.5 CJ CheilJedang Corporation (South Korea) Latest Developments
13.7 Evonik Industries AG (Germany)
13.7.1 Evonik Industries AG (Germany) Company Information
13.7.2 Evonik Industries AG (Germany) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.7.3 Evonik Industries AG (Germany) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Evonik Industries AG (Germany) Main Business Overview
13.7.5 Evonik Industries AG (Germany) Latest Developments
13.8 Meihua Holdings Group Co., Ltd. (China)
13.8.1 Meihua Holdings Group Co., Ltd. (China) Company Information
13.8.2 Meihua Holdings Group Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.8.3 Meihua Holdings Group Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Meihua Holdings Group Co., Ltd. (China) Main Business Overview
13.8.5 Meihua Holdings Group Co., Ltd. (China) Latest Developments
13.9 Shantou Jiahe Biological Technology Co., Ltd. (China)
13.9.1 Shantou Jiahe Biological Technology Co., Ltd. (China) Company Information
13.9.2 Shantou Jiahe Biological Technology Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.9.3 Shantou Jiahe Biological Technology Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shantou Jiahe Biological Technology Co., Ltd. (China) Main Business Overview
13.9.5 Shantou Jiahe Biological Technology Co., Ltd. (China) Latest Developments
13.10 Daesang Corporation (South Korea)
13.10.1 Daesang Corporation (South Korea) Company Information
13.10.2 Daesang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.10.3 Daesang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Daesang Corporation (South Korea) Main Business Overview
13.10.5 Daesang Corporation (South Korea) Latest Developments
13.11 Taj Agro Products (India)
13.11.1 Taj Agro Products (India) Company Information
13.11.2 Taj Agro Products (India) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.11.3 Taj Agro Products (India) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Taj Agro Products (India) Main Business Overview
13.11.5 Taj Agro Products (India) Latest Developments
13.12 Nutra Green (U.S.)
13.12.1 Nutra Green (U.S.) Company Information
13.12.2 Nutra Green (U.S.) Branched Chain Amino Acids (BCAAs) Product Portfolios and Specifications
13.12.3 Nutra Green (U.S.) Branched Chain Amino Acids (BCAAs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nutra Green (U.S.) Main Business Overview
13.12.5 Nutra Green (U.S.) Latest Developments
14 Research Findings and Conclusion